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Fig 1. Pre-op.
Fig 2. A, First stage repair; B, Second stage completion repair.
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(P < .05). Thus, we recommend that the TBI reference range be modi-
ﬁed to increase the clinical utility of this measurement and promote
timely intervention.
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Objectives: Although stent graft therapy has emerged as a treatment
option for dissection-related aneurysmal degeneration in the descending
thoracic aorta (DRAD DTA), questions remain concerning the incidence
of retrograde dissection, spinal cord ischemia, and secondary aortic
interventions.
Methods: Data on patients who underwent stent graft therapy for
DRAD DTA at a single institution between January 2006 and September
2013 were retrospectively analyzed. Perioperative and midterm outcomes
were assessed.
Results: Forty-ﬁve patients underwent stent graft therapy for DRAD
DTA during the study period. Patients were a mean age of 58 6 12 years,
and 73% (n ¼ 33) were men. Four patients (9%) underwent nonelective
repair for rupture or refractory pain. Previous type A dissection repair was
performed in 27% (n ¼ 12) of patients; 67% (n ¼ 8) of these patients
underwent aortic arch replacement or debranching before or at the time
of stent graft therapy. The left subclavian artery was covered in 49% (n ¼
22) of patients, and revascularization was performed in 86% (n ¼ 19).
Abdominal aortic debranching was performed in four patients. Spinal drains
were used in 73% (n ¼ 33) of patients. Spinal cord ischemia developed in
three patients: two cases resolved and one improved. There were no cases
of retrograde aortic dissection. The 30-day mortality was 4% (n ¼ 2); one
death was in a ruptured patient. Mean clinical follow-up was 29 6 21
months (two patients had no follow-up). Mean radiographic follow-up
was 25 6 16 months (four patients had no radiographic follow-up). Of
the 39 patients with radiographic follow-up, 85% (n ¼ 33) had reduced
or stable aneurysm diameters; 12% (n ¼ 4) of these patients underwent
secondary aortic interventions. An additional patient died during an attemp-
ted secondary aortic intervention. The 1-year and 3-year Kaplan-Meier sur-
vival was 91% and 84%, respectively (Fig).
Conclusions: Stent graft therapy can be performed safely and effec-
tively in the management of DRAD DTA. In this single-center study,
there were no cases of retrograde dissection and one case of permanent
spinal cord ischemia. Eighty-ﬁve percent of patients with radiographic
follow-up had reduced or stable aneurysm diameters. Aortic arch and
abdominal aortic interventions may play an important role in manage-
ment of DRAD DTA.
Fig. Kaplan-Meier survival of patients undergoing stent graft therapy of
dissection related aneurysmal degeneration in the descending thoracic aorta.
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Objectives: This study presents our results with a novel approach to
combined ascending/descending aortic aneurysms treated with staged
frozen elephant trunk technique.
Methods: Between January 2011 and December 2013, 149 pa-
tients underwent ascending and 38 descending thoracic aortic aneurysm
repairs at our institution. Within this cohort, ﬁve patients underwent
staged frozen elephant trunk technique as a treatment modality (Fig 1).
The ﬁrst stage involved sternotomy, cardiopulmonary bypass, and cir-
culatory arrest to allow replacement of the ascending aorta using a
hemiarch repair (Fig 2, A). Before closure of the distal arch anastomosis,
the Cook Zenith TX2 stent graft was unsheathed and directly anasto-
mosed to the aorta distal to the left common carotid or left subclavian
origin. Patients were allowed to recover and brought back for second
stage endovascular stent graft repair to exclude the descending aortic
aneurysm (Fig 2, B).
Results: There were no perioperative deaths, spinal cord ischemia, or
attachment site endoleaks. One embolic stroke occurred during the hemi-
arch repair. This patient recovered fully and subsequently underwent a suc-
cessful stent graft repair of her descending thoracic aortic aneurysm. No
secondary intervention has been needed to date, with median follow-up
of 13 months.
Conclusions: Although limited, our experience demonstrates that
the utilization of a commercially available stent graft can provide a consis-
tent and reliable device for use in the frozen elephant trunk. By concen-
trating our efforts initially to the open repair of the ascending/arch
segment, the need for extended circulatory arrest and thus systemic
ischemia is minimized. Subsequent staged endovascular repair of the
descending thoracic aortic segment is facilitated by the presence of a
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proximal anchor. Furthermore, the second stage with normal aortic
ﬂow allows for angiography-based deployment of the stent graft in the
aorta at its ideal distal anchoring site.
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Objective: Prior reports have suggested unfavorable outcomes after
endovascular aneurysm repair (EVAR) performed outside of the recommen-
ded instructions for use (IFU). We report our long-term EVAR experience
with regard to IFU in a large multicenter registry.
Methods: Between 2000 and 2010, 1736 patients underwent EVAR,
with 92% follow-up. Baseline anatomic measurements obtained from the
M2S Inc imaging database were compared with device-speciﬁc IFU. Pri-
mary outcomes were mortality and aneurysm-related mortality (ARM). Sec-
ondary outcomes were endoleak status, adverse events, and reintervention.
Results: During the median follow-up of 2.7 years, 489 patients
(28.2%) had preoperative anatomic data available. Overall, 58% had
EVAR performed within and 42% outside of IFU guidelines. Of the
outside-IFU patients, 62.4% had short neck length, 10.2% had greater angu-
lation, 7.3% did not meet neck diameter criteria, and 20% had multiple
anatomic issues. There was no difference in any of the primary or secondary
outcomes between the two groups (Table). The percentage change in
aneurysm sac size over time appeared similar (12.1% vs 14.1% at 5 years),
with no signiﬁcant difference in sac increase at any time point during follow-
up. Cox proportional hazard models showed that IFU nonadherence was
not predictive of overall mortality (hazard ratio [HR], 1.06; P ¼ .80), ARM
(HR, 0.17; P ¼ .07). or adverse events (HR, 0.84; P ¼ .61).
Conclusions: In our cohort of EVAR patients with detailed preop-
erative anatomic information and long-term follow-up, overall mortality
and ARM were unaffected by IFU adherence, despite a higher propor-
tion of women and larger aneurysms in the nonadherent group. In addi-
tion, rates of late endoleak and reintervention were similar, suggesting
that operator experience and patient selection inﬂuence outcomes despite
lack of IFU-based anatomic suitability.Table. Select demographics and outcomes by instructions for use (IFU)
status
Variable
IFU adherent
(n ¼ 284)
IFU nonadherent
(n ¼ 205) P
Female, % 6.7 14.6 <.01
Baseline AAA size, mm 56.6 59.7 <.01
Overall mortality, % 21.1 21.5 .93
ARM, % 2.8 1.0 .20
Type I/III leak, % 3.5 4.4 .62
Adverse events, % 8.8 11.2 .38
Reintervention, % 13.4 17.6 .20
AAA, Abdominal aortic aneurysm; ARM, aneurysm-related mortality.Author Disclosures: J. P. Walker: None; L. Tucker: None; P. Goodney:
None; H. Hua: None; S. Okuhn: None; A. Rhoades: None; B. Hill:
None; R. W. Chang: None.
Extended Proximal Seal Zone During EVAR Predicts Aneurysm Sac
Regression
Zachary M. Arthurs, MD,1 Kenneth Ouriel, MD,2 M. Burress Welborn
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Cardiovascular Surgical Associates, Jackson, MissObjective: The success of endovascular aneurysm repair (EVAR) is
often stratiﬁed in terms of proximal neck morphology. Irrespective of tradi-
tional aortic neck deﬁnitions, detailed imaging analysis of endograft-aortic
wall apposition may elucidate the effect of the seal zone extension on aneu-
rysm-related outcomes.
Methods: Core laboratory analysis of computed tomography (CT)
scans was performed in 41 patients undergoing EVAR with the AFX endog-
raft (Endologix, Irvine, Calif). AFX incorporates highly conformable
expanded polytetraﬂuoroethylene material external to the stent frame, mov-
ing independently to facilitate endograft-aortic wall apposition (ActiveSeal).
Aortic neck length was deﬁned as the infrarenal aortic length where the
aortic diameter remained within 10% of infrarenal reference. The effective
seal length and apposition surface area were determined based on the area
with 360o apposition between the graft material and the aortic wall. The
Pearson coefﬁcient was calculated between anatomic variables and the
amount of sac regression. Values are expressed as mean 6 standard
deviation.
Results: After implantation, the endograft was circumferentially
apposed to the aortic wall over a mean length of 28 6 17 mm, aver-
aging 5 mm more than the aortic neck length. By using standard deﬁ-
nition and during 12 6 5 months of follow-up, 98% of patients
exhibited sac regression or stabilization. Sac regression was positively
correlated with effective seal length (P < .05) and apposition surface
area (P < .05). Trends toward reduced sac regression in larger aneu-
rysms did not attain statistical signiﬁcance (P ¼ .075). Sac regression
was not associated with aortic neck length, diameter, angulation, or
thrombus/calcium composition.
Conclusions: Sac regression during EVAR using the AFX endograft
with ActiveSeal appears to correlate with the effective seal length and the
surface area of circumferential apposition between the aorta and the graft
material. When effective seal length and apposition are considered, tradi-
tional anatomic variables are not associated with aneurysm sac outcomes.
The ability of ActiveSeal to extend effective seal length beyond the anatomic
neck may constitute an additional consideration in planning of EVAR
procedures.
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Objective: Despite being rare (<0.7% population), renal artery aneu-
rysms (RAAs) represent the second most common visceral artery aneurysm
but have a relatively poorly understood natural history. Open surgery can be
extensive and usually involves ex vivo techniques, particularly because most
RAAs are in the distal renal artery or branch points. Endovascular repair of
RAAs can be technically challenging, depending on the branch point anat-
omy. We report a case of successful endovascular exclusion of two large
adjacent RAAs in a patient, which were unusually located in the proximal
renal artery.
Methods: A 68-year-old man with vague intermittent abdominal
discomfort was found incidentally to have two large proximal RAAs
measuring 5.4 cm and 3.9 cm (Fig). The larger, more distal aneurysm
was thrombosed, whereas the smaller, more proximal aneurysm came off
just distal to the renal ostium and was ﬁlling.
Results: The RAAs were successfully excluded after overlapping
placement of a 7-mm  50-mm Viabahn covered stent placed in the middle
to distal right renal artery from a femoral approach and a subsequent 7-mm
 38-mm iCAST covered stent protruding slightly into the aortic lumen
from a brachial approach. There were no postoperative complications, and
he has since been maintained on dual antiplatelet therapy. At the 2-year
follow-up, he remains asymptomatic, and imaging continues to demonstrate
exclusion and regression of both RAAs as well as normal renal arterial
perfusion.
Conclusions: Endovascular repair of RAAs via exclusion with covered
stents is a safe and effective therapeutic option when such aneurysms are
limited to the proximal or midportion of the renal artery. A brachial artery
approach is often required in such cases due to signiﬁcant renal artery tor-
tuosity or downward angulation.
